JP2016044170A5 - - Google Patents

Download PDF

Info

Publication number
JP2016044170A5
JP2016044170A5 JP2014172328A JP2014172328A JP2016044170A5 JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5 JP 2014172328 A JP2014172328 A JP 2014172328A JP 2014172328 A JP2014172328 A JP 2014172328A JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5
Authority
JP
Japan
Prior art keywords
stearic acid
excipient
olmesartan medoxomil
granulated product
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014172328A
Other languages
English (en)
Japanese (ja)
Other versions
JP6653116B2 (ja
JP2016044170A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014172328A priority Critical patent/JP6653116B2/ja
Priority claimed from JP2014172328A external-priority patent/JP6653116B2/ja
Publication of JP2016044170A publication Critical patent/JP2016044170A/ja
Publication of JP2016044170A5 publication Critical patent/JP2016044170A5/ja
Application granted granted Critical
Publication of JP6653116B2 publication Critical patent/JP6653116B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014172328A 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤 Active JP6653116B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019089234A Division JP6765473B2 (ja) 2019-05-09 2019-05-09 オルメサルタンのプロドラッグ製剤

Publications (3)

Publication Number Publication Date
JP2016044170A JP2016044170A (ja) 2016-04-04
JP2016044170A5 true JP2016044170A5 (enrdf_load_stackoverflow) 2017-08-24
JP6653116B2 JP6653116B2 (ja) 2020-02-26

Family

ID=55635052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014172328A Active JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Country Status (1)

Country Link
JP (1) JP6653116B2 (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI685483B (zh) 2014-02-13 2020-02-21 美商英塞特控股公司 作為lsd1抑制劑之環丙胺
RS59534B1 (sr) 2014-02-13 2019-12-31 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EA201792205A1 (ru) 2015-04-03 2018-02-28 Инсайт Корпорейшн Гетероциклические соединения как ингибиторы lsd1
UA126277C2 (uk) 2015-08-12 2022-09-14 Інсайт Корпорейшн Солі інгібітору lsd1
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
JP6765473B2 (ja) * 2019-05-09 2020-10-07 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤
EP4059504A4 (en) * 2020-01-16 2023-12-27 Eisai R&D Management Co., Ltd. LEMBOREXANT MEDICINAL COMPOSITION AND MEDICAL COMPOSITION CONTAINING SAME

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI367755B (en) * 2005-05-20 2012-07-11 Sankyo Co Film coated product
US20070105923A1 (en) * 2005-09-14 2007-05-10 Glenmark Pharmaceuticals Limited Substantially pure olmesartan medoxomil and processes for its preparation
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil
BRPI0809161A2 (pt) * 2007-03-23 2014-09-16 Daiichi Sankyo Co Ltd Olmesartan medoxomil, processos para a produção do mesmo, e, para a produção de um medicamento compreendendo olmesartan medoxomil, medicamento, e, uso de olmesartan medoxomil
WO2010018777A1 (ja) * 2008-08-11 2010-02-18 第一三共株式会社 におい抑制方法
EP2387392B1 (en) * 2008-12-30 2013-02-20 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Pharmaceutical formulations of olmesartan
HUP0900384A2 (en) * 2009-06-19 2011-01-28 Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag Nanoparticulate olmesartan medoxomil compositions
WO2011045760A2 (en) * 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Micronized olmesartan medoxomil compositions
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
WO2014080365A1 (en) * 2012-11-23 2014-05-30 Ranbaxy Laboratories Limited Method of reducing an unpleasant odor of a pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2016044170A5 (enrdf_load_stackoverflow)
RU2011141496A (ru) Таблетки и гранулированные порошки, содержащие 6-фтор-3-гидрокси-2-пиразинкарбоксамид
RU2020119391A (ru) Получение тетрациклического соединения, содержащегося в высокой дозе
IL233830B (en) Preparations of 3-(6-(1-(2,2-difluorobenzo{0}{1,3}dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid, methods for their staining and uses thereof
JP2015062904A5 (enrdf_load_stackoverflow)
HK1232218A1 (zh) Cgrp-活性化合物的片剂制剂
EP4327880A3 (en) Solid state form of ribociclib succinate
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
RU2019138248A (ru) Фармацевтическая композиция для перорального введения, содержащая энзалутамид
PH12019500610A1 (en) Controlled release tablet based on polyvinyl alcohol and its manufacturing
MY148878A (en) Stabilized amorphous forms of imatinib mesylate
PH12012502083A1 (en) Manufacturing of active-free granules and tablets comprising the same
MX2022015606A (es) Comprimidos de liberacion inmediata que contienen un farmaco y procesos para formar los comprimidos.
JP2018513863A5 (enrdf_load_stackoverflow)
IN2014DE03239A (enrdf_load_stackoverflow)
EA201500513A1 (ru) Продукт сомикронизации, включающий ацетат улипристала
JP2014024874A5 (enrdf_load_stackoverflow)
WO2012053785A3 (ko) 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛
JP2015129175A5 (enrdf_load_stackoverflow)
JP2014218523A5 (enrdf_load_stackoverflow)
JP2015129124A5 (enrdf_load_stackoverflow)
RU2016106384A (ru) Противотуберкулезная стабильная фармацевтическая композиция в форме таблетки с покрытием, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
JP2016011272A5 (enrdf_load_stackoverflow)
JP2012046484A5 (enrdf_load_stackoverflow)